Bengaluru-based healthtech startup Niramai Health Analytix’s patented, radiation-free breast cancer screening solution, Thermalytix®, has received CE mark approval, ISO 13485, and MDSAP (Medical Device Single Audit Programme) International Certifications.

Read more at: https://yourstory.com/2021/04/healthtech-startup-niramai-set-expand-global-markets

The health care startup’s AI-based, radiation-free method is making breast cancer screening more accessible
In 2013, as head of the data analytics team at a multinational technology company